Gaucher's Disease
Author:
- Arthur L. BeaudetABArthur L. Beaudet
- 5 March 1987
- journal article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 316 (10) , 619-621
Abstract
Traditionally, Gaucher's disease has been divided into three clinical forms, which have recently been reviewed.1 , 2 Type 1 disease is a non-neuronopathic, chronic disorder characterized by hypersplenism and bone involvement. This form is the most common lysosomal storage disease, with a frequency of about 1 in 2500 among Ashkenazic Jews. Although the bone involvement and rarer complications can cause substantial morbidity, the disease is usually compatible with a relatively normal life. Type 2 disease is a much rarer disorder, characterized by hepatosplenomegaly, central nervous system involvement, and death during infancy. Type 3 disease is defined by the onset of neurologic symptoms . . .Keywords
This publication has 6 references indexed in Scilit:
- A Mutation in the Human Glucocerebrosidase Gene in Neuronopathic Gaucher's DiseaseNew England Journal of Medicine, 1987
- Gaucher's disease type 1: assessment of bone involvement by CT and scintigraphyAmerican Journal of Roentgenology, 1986
- Gaucher disease: assessment with MR imaging.Radiology, 1986
- Effect of splenectomy on destructive bone changes in children with chronic (Type I) Gaucher diseaseEuropean Journal of Pediatrics, 1986
- Partial splenectomy in Gaucher's diseaseJournal of Pediatric Surgery, 1986
- Gaucher Type 1 (Ashkenazi) disease: a new method for heterozygote detection using a novel fluorescent natural substrateClinica Chimica Acta, 1982